Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
73 Cards in this Set
- Front
- Back
DEFINITION OF HYPERTENSION
|
A PROGRESSIVE CV SYNDROME WITH MANY CAUSES THAT RESULT IN BOTH FUNCTIONAL AND STRUCTURAL CHANGES TO THE HEART AND VASCULAR SYSTEM
|
|
HYPERTENSION WITH NO CLEARLY IDENTIFIABLE CAUSE (95%)
|
PRIMARY
|
|
TYPE OF HTN ASSOCIATED WITH SOME CLEARLY IDENTIFIABLE CAUSE
|
SECONDARY
|
|
NORMAL BP FOR ADULTS
|
<120 SBP; <80 DBP
|
|
PREHYPERTENSION
|
120-139 SBP OR 80-89
|
|
STAGE 1 HYPERTENSION
|
140-159 SBP OR 90-99
|
|
STAGE 2 HYPERTENSION
|
>160 OR >100
|
|
IDENTIFIABLE CAUSES OF HYPERTENSION
|
CHRONIC KIDNEY DZ, COARCTATION OF AORTA, CUSHING'S SYNDROME, DRUG INDUCED, PHEO, OBSTRUCTIVE UROPATHY, PRIMARY ALDOSTERONISM, RENOVASCULAR HYPERTENSION, SLEEP APNEA, THYROID OR PARATHYROID DISEASE
|
|
MOST COMMON FORM OF SECONDARY HYPERTENSION
|
RENAL PARENCHYMA DISEASE (ANY KIDNEY IMPAIRMENT MAY ALSO IMPACT BP CONTROL)
|
|
POSSIBLE CAUSES OF RENAL PARENCHYMA DISEASE
|
DIABETIC NEUROPATHY, GLOMERULONEPHRITIS, HYPERTENSIVE RENAL DISEASE (CULPRIT AND PROBLEM); DRUG INDUCED RENAL DZ, AND POLYCYSTIC KIDNEY DZ
|
|
CONSIDER FIBROMUSCULAR DYSPLASIA OF THE KIDNEYS IN WHAT PRESENTING PATIENTS?
|
YOUNG PEOPLE WITH ACUTE OR NEW ONSET OF RENAL FAILURE
|
|
WHAT ARE THE TWO PRIMARY MECHANISMS OF RENAL ARTERY STENOSIS?
|
ATHEROSCLEROSIS AND FIBROMUSCULAR DYSPLASIA
|
|
HOWD OES DIMINISHED RENAL BLOOD FLOW AFFECT THE BLOOD PRESSURE?
|
STIMULATES THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM, LEADNG TO INCREASED VOLUME RETENTION AND INCREASED BP
|
|
WHAT DOES RISING CREATININE AFTER INITIATION OF ACE INHIBITOR INDICATE?
|
RENAL ARTERY STENOSIS
|
|
WHAT DO YOU MONITOR WITHIN ONE MONTH OF PRESCRIBING ACE-I? WHY?
|
MONITOR BUN/CREATININE B/C ACE-I CAN INCREASE BP AND CAUSE KIDNEY FAILURE
|
|
HOW CAN RENAL ARTERY STENOSIS BE TREATED?
|
BALLOON OPEN ATHEROSCLEROTIC PLAQUE AND PLACE A STENT
|
|
WHAT IS COARCTATION OF THE AORTA?
|
RARE CONGENITAL NARROWING OF THE PROXIMAL AORTA NEAR THE ORIGIN OF THE LEFT SUBCLAVIAN ARTERY WHICH MAY LEAD TO HTN
|
|
WHAT WILL BE THE CHANGE IN THE UPPER EXTREMITY PULSES IN COARCTATION?
|
THE UPPER IMPULSES WILL BE BOUNDING
|
|
WHAT ARE THE CLASSICAL CLINICAL FINDINGS FOR COARCTATION?
|
RIB NOTCHING ON XRAY AND DIMINISHED FEMORAL PULSES
|
|
HOW DOES COARCTATION LEAD TO HTN?
|
INCREASED BP IN THE AORITC ARCH AND UPPER EXTREMITIES ACCELERATES ATHEROSCLEROSIS AND IMPAIRS BARORECEPTORS IN THE AORTIC ARCH; ALSO THERE IS IMPAIRED BLOOD FLOW TO DISTAL TO THE COARCTATION CAUSING IMPAIRED RENAL PERFUSION
|
|
WHAT IMAGING IS DONE FOR COARCTATION OF THE AORTA?
|
ANGIOGRAPHY
|
|
WHAT CAUSES RIB NOTCHING?
|
DILATED INTERCOSTAL ARTERIES (COARCTATION)
|
|
CATECHOLAMINE SECRETING TUMORS OF NEUROENDOCRINE CELLS, USUALLY LOCATED IN THE ADRENAL MEDULLA
|
PHEOCHROMOCYTOMA
|
|
HOW DOES A PHEO AFFECT BP?
|
THERE IS EPISODIC SECRETION OF CATECHOLAMINES THAT LEAD TO ACTIVATION OF THE SYMPATHETIC NERVOUS SYSTEM
|
|
CHARACTERISTIC SYMPTOMS OF A PHEO
|
EPISODIC HEADACHES, PALPITATIONS, AND DIAPHORESIS
|
|
MEN SYNDROMES TYPE 2A AND 2B ASSOCIATED WITH PHEOS USUALLY INVOLVE WHAT THREE CONDITIONS
|
MEDULLARY THYROID CARCINOMA; HYPERPARATHYROIDISM; AND RET ONCOGENE
|
|
WHAT IS CONN SYNDROME?
|
CAUSE OF HYPERALDOSTERONISM; ADRENAL ADENOMA THAT SECRETES EXCESS MINERALCORTICOIDS THAT INCREASED BP
|
|
TWO CAUSES OF HYPERALDOSTERONISM
|
CONN SYNDROME (ADRENAL ADENOMA) OR BILATERAL HYPERPLASIA ("PRIMARY" ALDOSTERONISM)
|
|
WHAT MECHANISM IN HYPERALDOSTERONISM CAUSES HYPERTENSION?
|
INCREASED SODIUM RETENTION DUE TO EXCESS OF ALDOSTERONE
|
|
CLASSIC FINDING OF HYPERALDOSTERONISM
|
UNPROVOKED HYPOKALEMIA (IN ABSENCE OF DIURETIC OR LATROGENIC CAUSE)
|
|
DIAGNOSIS FOR ALDOSTERONISM
|
ELEVATED 24 HR URINE ALDOSTERONE LEVEL; SERUM ALDOSTERONE: RENIN RATIO > 25:1
|
|
CUSHING'S DISEASE
|
PITUITARY ADENOMA THAT OVERPRODUCES ACTH
|
|
HOQ DOES CUSHING'S DISESE CAUSE HYPERTENSION?
|
EXCESS GLUCOCORTICOIDS (FROM ANY CAUSE) LEAD TO INCREASED BLOOD VOLUME AND RENIN PRODUCTION
|
|
DIAGNOSTIC TESTS FOR CUSHING'S SYNDROME
|
DEXAMETHASONE SUPPRESSION TEST; 24 HR URINE FREE CORTISOL LEVELS
|
|
HOW DOES HYPERTHYROIDISM LEAD TO HYPERTENSION?
|
EXCESS METABOLIC ACTIVITY LEADS TO CARDIAC HYPERACTIVITY AND INCREASED BLOOD VOLUME (BECAUSE THE TISSUES NEED MUCH MORE OXYGEN)
|
|
WHAT TYPE OF HYPERTENSION IS HYPERTHYROIDISM CLASSICALLY ASSOCIATED WITH?
|
SYSTOLIC HYPERTENSION
|
|
HYPOTHYROIDISM IS CLASSICALLY ASSOCIATED WITH?
|
DIASTOLIC HYPERTENSION
|
|
HOW DOES HYPERPARATHYROIDISM CAUSE HTN?
|
CAUSE AND EFFECT IS UNCLEAR; MAY BE ATTRIBUTED TO HYPERCALCEMIA AND POTENTIAL COEXISTING RENAL DYSFUNCTION
|
|
COMMON DRUGS THAT CAUSE HTN
|
ESTROGENS, CORTICOSTEROIDS, CYCLOSPORINE, ERYTHROPOIETIN, SYMPATHOMIMETIC DRUGS (PSEUDOEPHEDRINE, OTC COUGH SYRUPS), ALCOHOL, AND COCAINE
|
|
WHAT AMOUNT OF ALCOHOL CONSUMPTION HAS BEEN ASSOCIATED WITH HTN?
|
MORE THAN 2 DRINKS PER DAY
|
|
NEW ONSET OF HTN IN AN OLD PERSON IS PROBABLY DUE TO WHAT?
|
RENAL ARTERY STENOSIS OR DRUG INDUCED
|
|
WHAT IS DIAGNOSIS OF RESISTANT OR DIFFICULT-TO-CONTROL HTN BASED ON?
|
CONSISTENTLY ELEVATED BP MEASUREMENTS DESPITE ADHERENCE TO TREATMENT REGIMENTS CONTAINING 3 MEDS
|
|
WHAT IS AMBULATORY BP MONITORING USED FOR?
|
TO EVALUATE WHITE COAT HYPERTENSION; HYPOTENSIVE SYMPTOMS WITH ANTIHYPERTENSIVE MEDS, EPISODIC HYPERTENSION, AUTONOMIC DYSFUNCTION
|
|
AN ABSENCE OF 10-20 BP DROP WHILE SLEEPING MAY INDICATE WHAT?
|
INCREASED CVD RISK
|
|
FOLLOWUP FOR PATIENT WITH NORMAL BP WITH NO ACUTE END ORGAN DAMAGE
|
2 YEARS
|
|
FOLLOWUP FOR PATIENT WITH PREHYPERTENSION WITH NO ACUTE END ORGAN DAMAGE
|
RECHECK IN 1 YEAR
|
|
FOLLOWUP FOR PATIENT WITH STAGE 1 HYPERTENSION WITH NO ACUTE END ORGAN DAMAGE
|
CONFIRM WITHIN 2 MONTHS
|
|
FOLLOWUP FOR PATIENT WITH STAGE 2 HYPERTENSION WITH NO ACUTE END ORGAN DAMAGE
|
EVALUATE OR REFER FOR CARE WITHIN 1 MONTH; FOR THOSE WITH HIGHER PRESSURES, EVALUATE AND TREAT IMMEDIATELY (WITHIN 1 WEEK)
|
|
WHAT CAN BASELINE CHEST XRAY DONE IN HTN SHOW?
|
CARDIAC SILHOUETTE, RIB NOTCHING, PULMONARY OVERLOAD (HF), GREAT VESSEL ANOMALIES
|
|
WHY WOULD YOU DO ECHOCARDIOGRAPHY ON HTN PATIENT?
|
USED IN YOUNGER PATIENTS WHEN YOU HEAR A MURMUR AND SEE LVH ON EKG
|
|
WHAT IS THE BP GOAL FOR ALL PATIENTS WITH RENAL DYSFUNCTION?
|
130/80
|
|
FIRST LINE DRUG FOR HTN
|
THIAZIDE DIURETIC (UNLESS COMPELLING INDICATION)
|
|
FIRST LINE DRUG FOR HTN WITH DM/ RENAL DISEASE
|
ACE-I
|
|
FIRST LINE DRUG FOF HTN POST MI
|
BETA BLOCKER OR ACE-I (THEN ADD THIAZIDE)
|
|
FIRST LINE DRUG FOR HTN AND HF
|
BETA BLOCKER OR ACE-I
|
|
FIRST LINE DRUG FOR HTN AND STROKE PREVENTION
|
ACE-I AND A THIAZIDE
|
|
MOST EFFECTIVE LIFESTYLE MODIFICATION FOR HTN
|
WEIGHT LOSS
|
|
LIFESTYLE MODIFICATIONS FOR HTN
|
WEIGHT LOSS, DASH EATING PLAN, DIETARY SODIUM REDUCTION, AEROBIC PHYSICAL ACTIVITY, AND MODERATION OF ALCOHOL CONSUMPTION
|
|
WHAT LABS MUST BE MONITORED IN PATIENTS TAKING HYPERTENSIVE MEDS?
|
BUN/CR, HYDRATION STATUS, AND ELECTROLYTES (DO BMP)
|
|
LABETOLOL USED FOR?
|
HTN URGENCY
|
|
SEVERELY ELEVATED BP WITH CLINICALLY EVIDENT END ORGAN DAMAGE THAT REQUIRES IMMEDIATE THERAPY VIA IV
|
HYPERTENSIVE EMERGENCY
|
|
WHAT DIASTOLIC BP INDICATES HYPERTENSIVE CRISIS
|
GREATER THAN 130- BEWARE
|
|
WHAT IS THE CAUSE OF MOST HYPERTENSIVE CRISES?
|
CONSEQUENCE OF PROLONGED INADEQUATE CONTROL OF CHRONIC HYPERTENSION, OFTEN WITH SUPERIMPOSED ACUTE HEMODYNAMIC INSULT
|
|
WHY DO WE AVOID OVERLY RAPID REDUCTION OF BP IN HYPERTENSIVE CRISES?
|
IT MAY INDUCE WORSENED END ORGAN ISCHEMIA IF ELEVATED BP WAS A PHYSIOLOGIC COMPENSATION FOR A COEXISTING PATHOLOGIC PROCESS
|
|
THERAPEUTIC GOAL IN HYPERTENSIVE CRISES MANAGEMENT
|
PROMPT REDUCTION OF 20-25% AND A DIASTOLIC PRESSURE UNDER 100
|
|
WHAT DO PATIENTS WITH TRUE HYPERTENSIVE EMERGENCY REQUIRE?
|
ICU ADMISSION, PARENTERAL MEDICATIONS, CONTINUOUS CARDIAC MONITORING, INVASIVE BP MONITORING (RADIAL ARTERY LINE)**, ADJUSTMENT OF BP MEDICATION REGIMEN WHILE IN A CONTROLLED SETTING
|
|
HOW ARE PATIENTS WITH HYPERTENSIVE URGENCY WHO ARE NOT ADMITTED MANAGED?
|
ORAL MEDICATIONS BUT REQUIRE EXTENDED MONITORING PRIOR TO RELEASE AND CLOSE FOLLOW UP
|
|
APPROPRIATE INTERVENTIONS IN HYPERTENSIVE URGENCY WHEN PATIENTS ARE ALREADY BEING TREATED FOR HYPERTENSION
|
INCREASE DOSE OF EXISTING MEDICATIONS OR ADD ANOTHER AGENT; REINSTITUTE MEDS IN NON-ADHERENT PATIENTS; ADD DIURETIC AND EMPHASIZE SODIUM RESTRICTIONS
|
|
IF HYPERTENSIVE URGENCY IN A PREVIOUSLY UNTREATED PATIENT, WHAT CAN BE DONE?
|
ORAL FUROSEMIDE IF PT IS NOT VOLUME DEPLETED; ORAL CLONIDINE; OBSERVE FOR A FEW HOURS TO A REDUCTION OF 20 TO 30 MM HG; PRESCRIBE LONG ACTING AGENT AND FOLLOW UP WITH PCP WITHIN A FEW DAYS
|
|
DRUGS USED IN HYPERTENSIVE EMERGENCY
|
NITROPRUSSIDE, NICARDIPINE, LABETALOL, FENDOLDOPAM
|
|
HOW DOES NITROPRUSSIDE WORK IN HYPERTENSIVE EMERGENCY?
|
IT IS AN ARTERIOLAR AND VENOUS DILATOR; IS GIVEN VIA IV INFUSION AND WORKS IN A MATTER OR SECONDS WITH A QUICK HALF LIFE (CAUTIONS LONG TERM USE B/C OF CHANCE OF CYANIDE POISOINING)
|
|
WHAT CLASS OF DRUG IS FENOLDOPAM?
|
PERIPHERAL DOPAMINE-1 RECEPTOR AGONIST
|
|
2 MOST COMMONLY USED DRUGS IN HYPERTENSIVE EMERGENCY
|
IV SODIUM NITROPRUSSIDE AND RAPDI ACTING BETA BLOCKER
|